Your browser doesn't support javascript.
loading
In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.
Blackwell, T S; Blackwell, T R; Holden, E P; Christman, B W; Christman, J W.
Affiliation
  • Blackwell TS; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 27232, USA.
J Immunol ; 157(4): 1630-7, 1996 Aug 15.
Article in En | MEDLINE | ID: mdl-8759749
Search on Google
Database: MEDLINE Main subject: Acetylcysteine / Chemotactic Factors / Anti-Inflammatory Agents, Non-Steroidal / NF-kappa B / Growth Substances / Chemokines, CXC / Intercellular Signaling Peptides and Proteins / Endotoxins / Lung Diseases / Neutrophils Type of study: Etiology_studies / Prognostic_studies Language: En Journal: J Immunol Year: 1996 Type: Article Affiliation country: United States
Search on Google
Database: MEDLINE Main subject: Acetylcysteine / Chemotactic Factors / Anti-Inflammatory Agents, Non-Steroidal / NF-kappa B / Growth Substances / Chemokines, CXC / Intercellular Signaling Peptides and Proteins / Endotoxins / Lung Diseases / Neutrophils Type of study: Etiology_studies / Prognostic_studies Language: En Journal: J Immunol Year: 1996 Type: Article Affiliation country: United States